This is a demo store. No orders will be fulfilled.

Pharmaceuticals

  1. 19 Sep 2018  |  North America  |  Market Research

    Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022

    Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics

    The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...

    $4,950.00
  2. 24 Apr 2018  |  North America  |  Market Research

    Growth Insights—Real World Evidence Analytics Solutions Market

    Innovation and Changing End-user Needs Driving Market Growth

    Over the last 3-5 years, growing cost pressure on healthcare and pharmaceutical companies and a significant shift towards outcome based healthcare approach have resulted in companies increasingly adopting real world data and evidence solutions to optimize their operation and cost using analytics. Earlier, applications of RWE were largely limited to...

    $3,000.00
  3. 20 Nov 2017  |  North America  |  Market Research

    Global Biologics Market—Companies-to-Action

    Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development

    This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...

    $3,000.00
  4. 27 Sep 2017  |  Africa  |  Market Research

    East African Pharmaceutical Market, Forecast to 2021

    Generic Pharmaceutical Products Continue to Dominate with Increased Foreign Direct Investment by Asian Manufacturers

    Pharmaceutical markets in Sub-Saharan Africa are experiencing rapid growth as governments and healthcare providers battle with their respective burdens of disease. The continent has one of the highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities ...

    $4,950.00
  5. 16 Aug 2016  |  North America  |  Market Research

    Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

    Emerging Business Models Drive Transformation

    The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to c...

    $7,000.00
  6. 27 May 2016  |  Africa  |  Market Research

    Pharmaceutical Market Access Strategy for Ethiopia

    Landscaping New Investment Opportunities Across the Pharmaceutical Value Chain

    Scope of the report The research report includes the following segments: Product scope: Pharmaceutical Products Geographic scope: Ethiopia End-user scope: Pharmaceutical manufacturers, Pharmaceutical distributors, Healthcare providers, Contract Manufacturing Organisations (CMO) Revenue analysis and forecasts, drivers and restraints, business opp...

    $4,950.00
  7. 02 Mar 2015  |  North America  |  Market Research

    Vital Signs - The Analyst's Perspective - February 2015 Issue

    This market insight provides an analysis of the regulatory trends occurring in the US life sciences market. Included in this deliverable is an analysis of the new molecular entities (NMEs) approved by the US Food and Drug Administration and predictions for 2014. Trends are showing that the Food and Drug Administration is moving towards greater ef...

    $500.00